Listed by the USPTO as HUI, SAN MING R
Tech Center 1600 • Art Units: 1615 1617 1621 1627 1628 1629
This examiner grants 60% of resolved cases
HUI, SAN MING R works in Tech Center 1600 and Art Unit 1615. The profile covers 1324 resolved cases, with an allowance rate of 59.6%, an interview lift of 20.0%, and a median of 1085 days to allowance. The extensive case history supports using the allowance and timing figures for portfolio planning, while interviews remain a meaningful tactical option.
Neuroderm Ltd., Novartis AG, and Sony Group Corporation are the listed companies. GOODWIN PROCTER LLP, Knobbe, Martens, Olson & Bear, LLP, and STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C. are the listed firms. Counsel should prepare substantive responses carefully and use interviews to clarify the path toward allowable claim scope.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18739657 | COMBINATION | Non-Final OA | Novartis AG |
| 18570283 | METHOD FOR PREPARING FLUOROPHORE- AND CHROMOPHORE-CONTAINING CONJUGATES FOR VISUAL DETECTION OF ANALYTE MOLECULES | Non-Final OA | SONY GROUP CORPORATION |
| 18280877 | EP300 DEGRADER AND USES THEREOF IN NEUROBLASTOMA | Final Rejection | DANA-FARBER CANCER INSTITUTE, INC. |
| 18206947 | METHODS AND COMPOSITIONS FOR TREATING HERPESVIRUS INDUCED CONDITIONS | Final Rejection | TRUSTEES OF BOSTON UNIVERSITY |
| 18574883 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING KIDNEY INJURY, AND AUTOPHAGY ACTIVATOR | Non-Final OA | KYOTO UNIVERSITY |
| 17478112 | COMPOSITIONS AND METHODS FOR TREATING NONINFECTIOUS UVEITIS | Non-Final OA | CLEARSIDE BIOMEDICAL, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy59.6% of resolved applications examined by San Ming R Hui were allowed (1,324 resolved cases), compared with 43.4% across Art Unit 1615 over the last five years.
This examiner's interview lift is +20.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by San Ming R Hui took 1,085 days on average from filing to allowance.
San Ming R Hui examines applications in Art Unit 1615 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
